Valhi (VHI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Net income attributable to stockholders was $22.8M ($0.80/share) in Q4 2024, up from $4.9M ($0.17/share) in Q4 2023; full-year 2024 net income was $108.0M ($3.79/share) versus a net loss of $9.9M ($0.35/share) in 2023, driven by improved Chemicals Segment results and one-time gains.
Q4 2024 results benefited from a $31.4M gain related to an environmental remediation settlement, partially offset by non-cash deferred tax expenses totaling $24.7M.
Full-year 2024 included a $64.5M non-cash gain from the acquisition of the remaining 50% of Louisiana Pigment Company (LPC).
Financial highlights
Total net sales in Q4 2024 were $480.9M, up from $453.0M in Q4 2023; full-year 2024 net sales were $2.10B, up from $1.92B in 2023.
Operating income for Q4 2024 was $56.7M, up from $17.2M in Q4 2023; full-year operating income was $210.7M, up from $34.2M in 2023.
Interest expense increased by $6.4M in Q4 and $21.6M for the year due to higher rates and new debt from the LPC acquisition.
Segment performance
Chemicals Segment: Q4 2024 net sales rose 6% year-over-year to $423.1M; full-year sales up 13% to $1.89B. Q4 operating income was $32.6M (vs. $-1.6M), and full-year was $138.5M (vs. $-41.1M).
Component Products Segment: Q4 2024 net sales fell to $38.4M (from $43.2M); full-year sales were $145.9M (down from $161.3M). Q4 operating income was $4.9M (vs. $7.4M), and full-year was $17.0M (vs. $25.4M).
Real Estate Management and Development: Q4 2024 net sales were $19.4M (up from $9.7M); full-year sales were $71.8M (down from $93.9M). Q4 operating income was $19.2M (vs. $11.4M), and full-year was $55.2M (vs. $49.9M).
Latest events from Valhi
- Net loss in 2025 driven by weak Chemicals results, lower TiO2 prices, and higher costs.VHI
Q4 202510 Mar 2026 - Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing2 Dec 2025 - Annual meeting to elect seven directors and hold a say-on-pay vote, with online voting available.VHI
Proxy Filing2 Dec 2025 - Q3 2025 net loss of $22.2M driven by Chemicals segment decline and higher tax expense.VHI
Q3 20256 Nov 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 20257 Aug 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 202413 Jun 2025 - Q2 profit surged to $19.9M as Chemicals volumes rose and costs fell, despite higher interest.VHI
Q2 202413 Jun 2025 - Q1 net income surged on Chemicals growth and LPC acquisition, with a strong 2025 outlook.VHI
Q1 20256 Jun 2025